Anistreplase
From Wikipedia, the free encyclopedia
Image:Anistreplase.png | |
Anistreplase
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | 81669-57-0 |
ATC code | B01AD03 |
PubChem | ? |
DrugBank | BTD00102 |
Chemical data | |
Formula | C2569H3928N746O781S40 |
Mol. weight | 59042.3 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Anistreplase is a thrombolytic drug. It degrades plasminogen to plasmin, which in turn degrades fibrin (blood clots) to fibrin split products.
Also known as anisoylated plasminogen streptokinase activator complex (APSAC)